González-Rodríguez María, Ait Eldjoudi Djedjiga, Cordero-Barreal Alfonso, Farrag Mariam, Varela-García María, Ruiz-Fernández Clara, Torrijos-Pulpón Carlos, Lago Francisca, García-Caballero Lucía, Farrag Yousof, Conde-Aranda Javier, Pino Jesus, Gualillo Oreste
SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela Spain.
International PhD School University of Santiago de Compostela (EDIUS) Santiago de Compostela Spain.
JOR Spine. 2025 Jan 28;8(1):e70016. doi: 10.1002/jsp2.70016. eCollection 2025 Mar.
Intervertebral disc degeneration (IVDD) is one of the main causes of chronic low back pain. The degenerative process is often initiated by an imbalance between catabolic and anabolic pathways. Despite the large socio-economic impact, the initiation and progress of disc degeneration are poorly understood. Although intervertebral disc (IVD) and articular joint are not identical, their degenerative roads are remarkably similar. We, and another authors, previously demonstrated that E-74-like factor 3 (ELF3), a transcription factor induced by inflammatory mediators in various cell types including chondrocytes, is a central contributing factor for cartilage degradation. Thus, we aim to explore, for the first time, the expression, modulation, and the role of ELF3 in human IVD cells.
The presence of ELF3 in healthy and degenerated IVD tissues was initially determined by immunohistochemistry in annulus fibrosus (AF) and nucleus pulposus (NP). mRNA and protein expression were measured, respectively, by RT-qPCR and Western blot in AF and NP IVD cells harvested from healthy individuals and IVDD patients. Overexpression of ELF3 was performed by transfection of AF IVDD cells with pESE-1: ELF3 expression vector or pCI: empty vector.
Our results unveiled, for the first time, the expression of ELF3 in IVD tissues. ELF3 is notably upregulated in degenerated tissues compared to those from healthy patients. In addition, the stimulation of IVDD AF cells with various proinflammatory stimuli, showed marked increase in both mRNA and protein expression of ELF3. ELF3 overexpression in AF IVDD cells resulted in the upregulation of proinflammatory and catabolic genes such as PTGS2, NOS2, LCN2, IL-6, MMP13, and ADAMTS-5; whereas, ELF3 silencing resulted in the opposite results.
Our results support a novel role for ELF3 as a pro-inflammatory and pro-catabolic transcriptional mediator, whose targeting in IVD tissues might be of potential therapeutic relevance in disc degeneration.
椎间盘退变(IVDD)是慢性下腰痛的主要原因之一。退变过程通常由分解代谢和合成代谢途径之间的失衡引发。尽管椎间盘退变对社会经济有重大影响,但其起始和进展机制仍知之甚少。虽然椎间盘(IVD)和关节并不完全相同,但它们的退变途径非常相似。我们和其他作者之前已证明,E-74样因子3(ELF3)是一种在包括软骨细胞在内的多种细胞类型中由炎症介质诱导产生的转录因子,是软骨降解的一个关键促成因素。因此,我们旨在首次探索ELF3在人IVD细胞中的表达、调控及其作用。
首先通过免疫组织化学法检测健康和退变的IVD组织中纤维环(AF)和髓核(NP)内ELF3的存在情况。分别采用逆转录定量聚合酶链反应(RT-qPCR)和蛋白质印迹法检测从健康个体和IVDD患者获取的AF和NP IVD细胞中的mRNA和蛋白质表达。通过用pESE-1:ELF3表达载体或pCI:空载体转染AF IVDD细胞来实现ELF3的过表达。
我们的结果首次揭示了ELF3在IVD组织中的表达。与健康患者的组织相比,退变组织中ELF3明显上调。此外,用各种促炎刺激物刺激IVDD AF细胞后,ELF3的mRNA和蛋白质表达均显著增加。AF IVDD细胞中ELF3的过表达导致促炎和分解代谢基因如PTGS2、NOS2、LCN2、IL-6、MMP13和ADAMTS-5上调;而ELF3沉默则产生相反的结果。
我们的结果支持ELF3作为一种促炎和促分解代谢转录介质的新作用,其在IVD组织中的靶向作用可能对椎间盘退变具有潜在的治疗意义。